Research Topics
| Teruhiko TerasawaSummaryAffiliation: Tufts Medical Center Country: USA Publications
|
Detail Information
Publications
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomesTeruhiko Terasawa
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
Leuk Lymphoma 50:1750-2. 2009..Its use should currently be reserved for research studies where treatment strategies and imaging protocols are standardized...- Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: a multiple-treatment meta-analysisTeruhiko Terasawa
Department of Internal Medicine, Nanakuri Sanatorium, Fujita Health University School of Medicine, Tsu, Japan
Cancer Treat Rev 39:340-9. 2013..In conclusion, published randomized evidence on overall survival is insufficient to recommend any particular first-line treatments. Any progression-free survival differences may be applicable to relatively young uncomplicated patients... - Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic reviewTeruhiko Terasawa
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
J Clin Oncol 27:1906-14. 2009.... 
Systematic review: charged-particle radiation therapy for cancerTeruhiko Terasawa
Tufts Medical Center Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
Ann Intern Med 151:556-65. 2009..Radiation therapy with charged particles can potentially deliver maximum doses while minimizing irradiation of surrounding tissues, and it may be more effective or less harmful than other forms of radiation therapy...
Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysisTeruhiko Terasawa
Fujita Health University Nanakuri Sanatorium, 424 1 Odoricho, Tsu, Mie, 514 1295, Japan
Oncologist 15:750-9. 2010....- Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task ForceMei Chung
Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 155:827-38. 2011..Studies suggest that vitamin D supplementation may reduce cancer and fracture risks... - Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic reviewEthan M Balk
Tufts Evidence based Practice Center, TuftsMedical Center, Boston, Massachusetts, USA
J Cardiovasc Electrophysiol 21:1208-16. 2010..AF Recurrence After RFA: Systematic Review... - 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic reviewTeruhiko Terasawa
Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
J Nucl Med 49:13-21. 2008..The aim of this study was to systematically review the diagnostic accuracy of (18)F-FDG PET in detecting residual disease at the completion of first-line therapy of Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL)... - Systematic review to support the development of nutrient reference intake values: challenges and solutionsMei Chung
Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA02111, USA
Am J Clin Nutr 92:273-6. 2010..The experiences described in this article can serve as a basis for future improvements in systematic reviews of nutrients and to better integrate systematic review into development of future nutrient reference values... - Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancerIssa J Dahabreh
Center for Clinical Evidence Synthesis, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 154:37-49. 2011..KRAS mutations have been extensively investigated as predictive biomarkers for treatment of advanced colorectal cancer with the anti-epidermal growth factor receptor (EGFR) antibodies cetuximab and panitumumab... - CYP2D6 testing to predict response to tamoxifen in women with breast cancer: PharmacogenomicIssa Dahabreh
ICRHPS, Tufts Medical Center Department of Internal Medicine, Fujita Health University School of Medicine Tufts Medical Center and Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
PLoS Curr 2:RRN1176. 2010..A test predicting lack of response to tamoxifen could supplement information used by clinicians and patients in treatment decision-making. For example, physicians and patients may opt to switch to an alternative therapy upfront... - Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillationTeruhiko Terasawa
Tufts Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 151:191-202. 2009..Atrial fibrillation is the most common sustained arrhythmia. Medical treatment often fails to control symptoms... - BCR-ABL mutation testing to predict response to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaTeruhiko Terasawa
Department of Internal Medicine, Fujita Health University School of Medicine ICRHPS, Tufts Medical Center and Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
PLoS Curr 2:RRN1204. 2010..Testing for mutations in BCR-ABL1 may predict lack of response to imatinib or may inform the choice between alternative TKIs...